Human cl rhFVIII

BIOLOGICAL2 trials

Sponsors

Octapharma

Conditions

Severe Haemophilia ASevere Hemophilia A

Phase 3

Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients

CompletedNCT01712438

OctapharmaSevere Hemophilia A

Start: 2013-02-28End: 2019-12-20Updated: 2021-01-19

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

CompletedNCT02256917

OctapharmaSevere Haemophilia A

Start: 2015-05-31End: 2018-09-30Updated: 2021-01-19

Related Papers

Transcriptomic Profiling to Understand Inhibitor Development in Previously Untreated Patients with Severe Hemophilia a

Blood2023-11-02